Member Info for Early_Bird

no surprises tbh. Fully expect another day of the same tomorrow.

This deposit repayment from a gas contract made in 2013 I think has gone completely unnoticed by the market. As per interim results this £485k incoming plus £540k in cash means £1.025M cash take off say a conservative £200k cash burn in the past 5 months (i think its much less than this now due to directors being paid in shares) gives £825k cash in the kitty vs £450k MC, no debt, and a new focus on fintech investments as of 3rd of march if voted through. Thats all completely ignoring the £560k they have in O&G investments... you can chuck these in for free. Could be potentially quite an exciting period coming IMO.

Interim results here have some pretty important and material information hidden in them If you read section 7 for receivables: "On 10 January 2013, the Group entered into a contract to purchase 20,000 cubic meters of Gasoil at a price of US$775 per cubic meter. On entering the contract the Group paid a refundable deposit of £499,900. If the Group chooses not to perform on the contract, the deposit will be refunded. The contractor, at their sole discretion, has the right to impose a 2.25% fee for any amounts refunded for non-performance" So that's £485k net cash to be received if they opt out of this contract. Then go to section 12 "The Company on December 3rd notified its intent not to perform on the Gasoil contract and has requested to be refunded the amount owing. These funds will be received in early January 2016." So according to this MMO should now have around £1M in cash, £500k in assets, liabilities I get down to around £100k as were paid in October using equity... MC of £400k and as of 3rd march look to be going in to Fintech investments... To me this is very materially significant for the company that £500k cash payment incoming so I wonder why not RNS? The fact that directors are being paid now in shares at a nice premium is also encouraging.

http://www.mercomoil.com/Mercom_Oil_Sands_PLC_-AGM_Circular.pdf Resolution 1 to be proposed at the AGM seeks to amend the Investing Policy by extending the policy to enable the Directors, in addition to making investments in the natural resources and energy sectors (with a focus on oil and gas), to make investments in the financial services and financial services technology (Fintech) sectors, these being sectors in which the Board considers it has sufficient experience Fintech very hot sector. With MMO £500k in cash and £500k in an investment this could start moving bigtime IMO.

"Eagle Bird" I like it ;) Cheers KUMS, im also pretty maxed out here in terms of my exposure, so its a case of sittnig tight and let the news do the talking when that lands. Buying inside 3p is indeed a nil brainer.

welcome! Interesting series of quickfire trades just now. around 600k more buys than sells today thus far including isdx so tick blue soon IMO

Exactly Kingbob, cash fully backs up the market cap here which is the beauty of it. Hardly any downside vs huge potential upside with the calibre of directors and the connections and expertise in biopharma they have. Not many directors on AIM have an OBE for starters... He was awarded OBE in 2007 for his contribution to the Scottish Life Sciences and biotech industry. Harry Stratford is the equivalent of having a Dragon on board. Pretty sure at his age would only be getting involved if he thought this could be the start of something very exciting and worthwhile!

*unless he was very confident

wouldnt spend £880k of his own money to buy other significant holders out at 4p (taking an immediate £400k hit) in order to secure the vote to biopharma unless he wasnt very confident. add Harry Stratford appointment and you can get a flavour of the size of deal being lined up IMO.

welcome cityal! certainly a very solid bunch of investors in this stock and for good reason, it ticks every single shell box. Still only valued at cash only now with Harry Stratford priced in at 0! Cash position.. tick Management... double tick Hot Target Sector.. tick

All the reststance that was previously at 2.85p on the book a few weeks back has now gone. This looks ready to move, im getting excited here, news cant be far off now.

Harry Stratford recently been made a director as Consilient Health Ltd just over a year ago, a private biopharma company based in Ireland... The latest accounts show a huge improvement in net worth, up over 200% since 2014 from €8m to €26.1m.. wonder if that's known as the Stratford effect? Anyway....2015 balance sheet numbers look impressive €40m turnover, €10m Gross profit and €4M Operating profit (net) with €27m in cash... You can imagine.. just to give a flavour of the potential if FAST (a public company) RTO a company like Consilient (private company) the scope to realise value... a public company on AIM with these balance sheet numbers would be trading £60-80M MC no problem... whereas in a private domain they could probably get bought for far far less than this value... £15M net worth. This just gives a flavour of the sort of potential an RTO can realise. Combine with the scalability that a director like Harry Stratford can bring (essentially like a Dragon from dragons den)... chuck in a NASDAQ listing and suddenly you are looking at a huge valuation potential. Reference for figures here: https://beta.companycheck.co.uk/company/IE347231/CONSILIENT-HEALTH-LIMITED/summary

My personal price targets in FAST for short, medium, long term along with reasoning are as follows: • Short term (0-4weeks): 5p • Medium term (1-3months): 8p (likely to be in suspension during this time due to RTO) • Long term (4-12months): 15p Short Term Reasoning: Is based on technicals. people catching on to what is on offer here with: • 2.8p cash (£9.5M) / no debt. • CEO Cathal Friel buying all other significant holders out with £880k of his own dosh at 4p (note - this was 100% premium to SP at the time) which enabled him to secure the change from O&G to Biopharma in the vote – he wouldn’t pay such a premium if he wasn’t very confident of a move to biopharma. • Recent appointment of Harry Stratford – only now have people started looking in to this guy’s credentials. He was the founder of Shire – one of the UK largest Pharma Companies MC around $40billion, Harry started from a room in his house with his wife, he was founder and CEO at Shire for a decade. Following Shire he started another Pharma company from scratch, ProStrakan and built this to £300M MC. • Charts: Golden cross emerging. Golden Cross indicates a bull market on the horizon and is reinforced by high trading volumes . Additionally, the long-term moving average becomes the new support level in the rising market. Technicians might see this cross as a sign that the market has turned in favour of the stock. Compare FAST with other shells and I cant find any with the director credentials and cash/MC ratio even in the near ballpark. Most with these director credentials are trading at 200% premium to cash minimum (and to be honest I think FAST now has best director credentials of any AIM shell). Medium Term Reasoning: In the next 1 – 3 months I would expect some updates giving the market more detail in to the targeted Biopharma company being lined up for RTO, with likely share suspension until RTO deal completes. Things we know are that Biopharma company being targeted is in the European market and has products near/ready to market for near term revenue generation with global scalability. I think the recent appointment of HS reinforces that the deal being worked will have fantastic scope to be scaled up to huge European/global markets. Long Term Reasoning: SP of 15p equates to a Market Capital of around £50M. If we look at MTFB, junior biopharma company recently to market this is a good example of lower end of what we can expect with FAST in the first 6 months of RTO. An investment should always be based on risk/reward basis IMO. With FAST downside is backed up by 2.8p cash and v small cash burn, therefore limited…. upside - just google Harry Stratford.

Yes but 3p is the resistance point, if we break that then some real gains could come fast.

*bucket

shouldnt have many more left now totalling up the large sell trades. They are the hole in the backet so once gone should lift nicely

Excellent news today, dissapointing that the rise didnt hold but CSS still have a chunk to sell so until theyre gone there is a hole in the bucket. Marathon not a sprint. GLA

buys here today... I feel an attack of 3p soon

this fecker was on something like £500k pa salary! Viva la revolution!

Positive change IS happening. Fantastic! http://uk.advfn.com/stock-market/london/peertv-PTV/share-news/PeerTV-PLC-Resignation-of-CEO/70112590